High blood pressure (Hypertension) News

Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension - AstraZeneca

Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension AstraZenecaAstraZeneca's blood pressure drug wins U.S. approval ReutersAstraZeneca wins nod for blood pressure pill, opening new class of hypertension drugs BioSpaceAstraZeneca notches key FDA nod in hypertension, with an approval sweetener for Fasenra too Fierce PharmaNew Pill Lowers Stubborn Blood Pressure and Protects the Kidneys SciTechDailyAstraZeneca's blood pressure pill approved, but competition could be around the corner Endpoints News